Developer docs
API playgroundTry for free, no card

Search company profiles

Neuberg Diagnostics

Full company profile

uuid0000a41

Namestring
Neuberg Diagnostics
Legal namestring
Neuberg Diagnostics Private Limited
Company typeenum
Private
Founded yearint
1938
Descriptiontext

Neuberg Diagnostics operates a multi-channel clinical laboratory and diagnostic services platform headquartered in Chennai, India, with a network spanning 250+ lab networks and 10,000+ touchpoints across 250+ Indian cities and 5,500+ pincodes, plus international operations in the UAE, South Africa, and the USA. Founded in 2015 by Dr. G.S.K. Velu as part of an International Diagnostics Alliance, the company offers 6,000+ pathological investigations spanning genomics, metabolomics, proteomics, biochemistry, microbiology, hematology, histopathology, molecular biology, and oncopathology, supported by 200+ in-house pathologists and reference laboratories in Bangalore, Ahmedabad, and Durban with CAP and NABL accreditation. In 2024 it launched the Geniee personalized genomics platform (wellness, pharmacogenomics, and screening for 2,300+ genetic conditions), and in 2026 it deployed a multi-agent AI system for Sigma-metrics quality control that reduces processing time from 15 days to under 60 minutes across ~130 assays.

The company serves three distinct customer segments: individual consumers (direct-to-consumer tests and packages booked online, via app, or through home sample collection), corporate clients (recurring wellness subscriptions covering pre-employment, annual, and executive health checks across banking, IT/ITES, manufacturing, FMCG, PSU, automotive, education, and travel sectors), and hospital/healthcare facilities (managed hospital lab outsourcing covering infrastructure, IT integration, and accreditation). Pricing for individual tests ranges from Rs. 85 to Rs. 1,690 and bundled health packages from Rs. 865 to Rs. 34,999, with genetic testing reaching Rs. 35,000 on the Geniee Platinum tier; a Rs. 999 monthly Doctor's Care Card subscription adds a recurring layer. Reported scale is 30+ million tests processed annually with public discounting of 29%–74% off listed menu prices.

The revenue base is projected by management at Rs. 16 billion for FY2026E and Rs. 20 billion for FY2027, with the company valued at approximately $547 million as of December 2025 following pre-IPO investments of Rs. 1,300 crore from Quadria Capital (2023) and Rs. 940 crore from Kotak Strategic Situations India Fund II (January 2025). A public listing is targeted for 2026 at a raise size of approximately $350 million, with proceeds and existing capital directed toward expansion, M&A, and personalized-medicine capability buildout.

Short descriptiontext

Neuberg Diagnostics is an Indian clinical laboratory chain offering 6,000+ pathology and genomic tests through 250+ lab networks and 10,000+ touchpoints. Founded in 2015 by Dr. G.S.K. Velu, it processes 30+ million tests annually across consumers, corporates, and hospitals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersChennai, India
HQ citystring
Chennai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic services, clinical laboratory, pathology testing, genomic testing, corporate wellness
Industry3 codes
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Laboratory Testing Services
TypeOne Time License
Description

Core revenue from pathology and radiology diagnostic testing services. Individual tests range from Rs. 85 to Rs. 1,690, with health packages from Rs. 865 to Rs. 34,999. Revenue also generated from specialized tests including genetics and genomics.

neubergdiagnostics.com
2Corporate Wellness Programs
TypeSubscription Recurring
Description

B2B services offering comprehensive health packages for corporate employees including pre-employment checks, annual health checks, executive health checks, and on-site health camps across industries.

neubergdiagnostics.com
3Hospital Lab Management
TypeManaged Services
Description

Managed services for hospital laboratories including infrastructure upgrade, IT integration, quality accreditation (NABL/ISO/CAP), and process optimization.

neubergdiagnostics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details4 tiers
1Individual Lab Tests
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single tests range from Rs. 85 (Glucose-Fasting) to Rs. 1,690 (25 OH Cholecalciferol). Common tests include: CBC at Rs. 350, Lipid Profile at Rs. 700, Liver Function Test at Rs. 830, Thyroid Function Test at Rs. 750, HbA1c at Rs. 550.

neubergdiagnostics.com
2Health Packages
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Packages range from Rs. 865 (Diabetes Care Basic - 7 tests) to Rs. 34,999 (Geniee Wellness Super Premium). Major packages include: Annual Health Check Basic at Rs. 1,945 (78 tests), Annual Health Check Vita at Rs. 3,025 (107 tests), Master Health Checkup at Rs. 6,480 (105 tests).

neubergdiagnostics.com
3Genetic Testing (GENIEE)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

GENIEE Platinum at Rs. 35,000 covering wellness genomics, pharmacogenomics (170 drugs), and genetic health screening (2300+ conditions). GENIEE Wellness at Rs. 22,000 covering 59 wellness traits and pharmacogenomics.

neubergdiagnostics.com
4Doctor Care Card
ModelSubscriptionBilling cadenceMonthly
Notes

Doctor's Care Card offering 30% off on routine blood tests, free home sample collection, and Dr Care Package at Rs. 999 covering Liver Function Test, Kidney function test, CBC, HbA1c, Vitamin D.

neubergdiagnostics.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Geniee
Description

Personalized genomics platform offering wellness genomics, pharmacogenomics, and genetic health screening. Covers 59 genetic traits for nutrition, fitness, and disease susceptibility; personalized medication response for 170 drugs; and comprehensive risk assessment for 2,300+ genetic conditions.

neubergdiagnostics.com
Core offering1 text field

Neuberg Diagnostics operates clinical laboratory and diagnostic testing services across India, UAE, South Africa, and the USA, offering over 6,000 varieties of pathological investigations including routine pathology, biochemistry, microbiology, hematology, histopathology, molecular biology, oncopathology, and personalized genomics. The company provides direct-to-consumer testing through 250+ lab networks, home sample collection, and digital report delivery, alongside B2B hospital lab management and corporate wellness programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced Sigma metrics computation from 15 days to under 60 minutes for 130 assays through agentic AI implementation
+2 more records
Product overview1 text field

Neuberg Diagnostics is a multi-channel diagnostic services platform operating as a unified brand across pathology, radiology, and genomics. The core platform offers 6,000+ pathology tests and radiology imaging (X-ray, MRI, ultrasound, CT scan) through 250+ lab networks in India, UAE, South Africa, and the USA, accessible via web portal, mobile app, and home sample collection. The GENIEE sub-brand provides three tiers of personalized genomics products (Platinum, Wellness, Drug Response) which integrate genetic screening with the core diagnostic testing menu. Doctor First is a public health initiative built into the platform to drive appropriate clinical engagement. Corporate Wellness and Hospital Lab Management are B2B add-on modules that extend the core platform to enterprise clients and healthcare institutions.

Product and service7 records
1Clinical Laboratory Testing
CategoryDiagnostic Services
Description

Core clinical laboratory testing services including routine pathology, biochemistry, microbiology, hematology, and specialized tests. Tests range from Rs. 85 (Glucose-Fasting) to Rs. 1,690 (25 OH Cholecalciferol). Over 6,000 varieties of pathological investigations are offered across 250+ lab networks in India, with home sample collection and online report delivery. Targets individual patients seeking diagnostic tests.

2Health Check-up Packages
CategoryDiagnostic Services
Description

Pre-bundled health check-up packages combining multiple tests at discounted prices, ranging from Rs. 865 (Diabetes Care Basic, 7 tests) to Rs. 34,999 (Geniee Wellness Super Premium). Includes packages like Her Essential Basic (79 tests at Rs. 2,199), Master Health Checkup (105 tests at Rs. 6,480), and Annual Health Checkup variants. Targets individual consumers seeking preventive health screenings.

3GENIEE Personalized Genomics Platform
CategoryGenomic Testing
Description

Personalized genomics sub-brand offering genetic screening across three tiers: GENIEE Platinum (Rs. 35,000, covering wellness genomics, pharmacogenomics for 170+ drugs, and health screening for 2,300+ conditions), GENIEE Wellness (Rs. 22,000, covering 59 wellness traits and pharmacogenomics), and Drug Response tiers. Provides insights on nutrition, fitness, medication response, and hereditary disease risks. Targets health-conscious individual consumers and patients.

4Corporate Wellness Program
CategoryCorporate Wellness
Description

B2B corporate wellness services offering comprehensive health packages for corporate employees including pre-employment checks, annual health checks, executive health checks, on-site health camps, and insurance medical checks across banking, IT/ITES, manufacturing, FMCG, PSU, automotive, education, and travel sectors. Targets HR heads and corporate wellness managers.

5Hospital Lab Management Services
CategoryDiagnostic Services
Description

Managed services for hospital laboratories including infrastructure upgrade, IT integration with hospital LIS systems, staff training, quality and accreditation support (NABL/ISO/CAP), process optimization, and business development. Targets hospital administrators and healthcare facility operators.

6Home Sample Collection
CategoryDiagnostic Services
Description

Home visit sample collection service allowing patients to book sample collection from their homes. Available across service areas with dedicated phone lines (89390 66655) and online booking through website and app. Targets individual consumers preferring at-home convenience.

7Doctor Care Card
CategoryMembership Program
Description

Subscription-based membership card for doctors and their families offering 30% off on routine blood tests, free home sample collection, and access to Dr Care Package at Rs. 999 covering Liver Function Test, Kidney function test, CBC, HbA1c, and Vitamin D. Targets medical professionals and their families.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-18
Description

bioMerieux collaborated on Pre-Conference Workshop on Sepsis Solutions at PathFinders 2024. Dr. Debkishore Gupta (Director and Head, Medical Affairs, bioMerieux South Asia) and Dr. Devjani De (Lead, Medical Affairs, bioMerieux South Asia) served as workshop faculty covering antimicrobial interpretation, sepsis diagnostics, and syndromic approach.

2IAPM (Indian Association of Pathologists and Microbiologists) - Tamil Nadu Chapter
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PathFinders 2024 conference organized under the aegis of TamilNadu and Pondicherry Chapter of IAPM - TNCIAPM, focused on 'Integrated Diagnostics: Trends Defining the Future of Diagnostic Medicine'.

neubergdiagnostics.com
Strategic tierMinorTypeOthers
Description

Conference venue partner for PathFinders 2024 conference held on July 20-21, 2024.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Kumar Shubham (Associate Vice President, Labsystems Diagnostics Oy, Finland) contributed to Pre-Conference Workshop on Newborn Screening Solutions at PathFinders 2024.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Santosh Devraj Pradhan (Assistant Product Manager, Trivitron Healthcare, India) contributed to Newborn Screening Workshop. GSK Velu is also preparing Trivitron Healthcare for public listing.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India's largest diagnostic chain by revenue and network. Directly comparable in clinical lab services, B2B hospital partnerships, and home sample collection; Neuberg is positioned as the #4 challenger to Dr. Lal's #1 incumbency.

TypeDirect peer
Description

Listed Indian diagnostic chain with comparable B2B hospital lab management, corporate wellness, and specialty testing offerings. Competes head-to-head in metros and offers a directly comparable public-market benchmark for Neuberg's pre-IPO valuation.

TypeDirect peer
Description

Pan-India diagnostic chain owned by Fortis Healthcare. Overlaps with Neuberg across pathology, reference lab services, hospital partnerships, and corporate wellness — one of the top three players against which Neuberg directly competes.

TypeDirect peer
Description

Volume-focused diagnostic network acquired by PharmEasy. Directly comparable in low-cost preventive health packages and pan-India B2B2C distribution; competes with Neuberg on package pricing strategy.

TypeDirect peer
Description

Diagnostic arm of Apollo Hospitals. Directly comparable in hospital-affiliated lab services, preventive health packages, and home sample collection across India, leveraging Apollo's hospital referral network.

TypeEmerging player
Description

India-based diagnostic chain expanding aggressively in North and East India. Comparable in B2B hospital lab management and preventive packages; smaller than Neuberg but pursuing similar pan-India consolidation strategy.

TypeRegional player
Description

Strong regional diagnostic chain in Western and Central India. Overlaps with Neuberg on B2C pathology, corporate wellness, and home collection but with limited national or international footprint versus Neuberg's 250+ city network.

TypeEmerging player
Description

Digital-first Indian diagnostic platform with strong home-sample-collection flywheel. Competes with Neuberg on tech-led DTC booking and at-home preventive packages but lacks reference-lab depth and B2B hospital presence.

TypeEmerging player
Description

Digital health platform backed by Tata Group offering diagnostic booking. Partially overlaps with Neuberg's DTC booking and home-collection but operates a marketplace model rather than owned labs at Neuberg's scale.

TypeOthers
Description

Medical technology and IVD company also founded by GSK Velu and slated for IPO. Not a direct competitor but is a sister company and ecosystem participant — provides IVD equipment and reagents, with overlapping newborn screening collaboration at PathFinders 2024.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Neuberg Diagnostics

Diagnostic Servicesneubergdiagnostics.com

Neuberg Diagnostics is an Indian clinical laboratory chain offering 6,000+ pathology and genomic tests through 250+ lab networks and 10,000+ touchpoints. Founded in 2015 by Dr. G.S.K. Velu, it processes 30+ million tests annually across consumers, corporates, and hospitals.

What Neuberg Diagnostics does

Neuberg Diagnostics operates a multi-channel clinical laboratory and diagnostic services platform headquartered in Chennai, India, with a network spanning 250+ lab networks and 10,000+ touchpoints across 250+ Indian cities and 5,500+ pincodes, plus international operations in the UAE, South Africa, and the USA. Founded in 2015 by Dr. G.S.K. Velu as part of an International Diagnostics Alliance, the company offers 6,000+ pathological investigations spanning genomics, metabolomics, proteomics, biochemistry, microbiology, hematology, histopathology, molecular biology, and oncopathology, supported by 200+ in-house pathologists and reference laboratories in Bangalore, Ahmedabad, and Durban with CAP and NABL accreditation. In 2024 it launched the Geniee personalized genomics platform (wellness, pharmacogenomics, and screening for 2,300+ genetic conditions), and in 2026 it deployed a multi-agent AI system for Sigma-metrics quality control that reduces processing time from 15 days to under 60 minutes across ~130 assays.

The company serves three distinct customer segments: individual consumers (direct-to-consumer tests and packages booked online, via app, or through home sample collection), corporate clients (recurring wellness subscriptions covering pre-employment, annual, and executive health checks across banking, IT/ITES, manufacturing, FMCG, PSU, automotive, education, and travel sectors), and hospital/healthcare facilities (managed hospital lab outsourcing covering infrastructure, IT integration, and accreditation). Pricing for individual tests ranges from Rs. 85 to Rs. 1,690 and bundled health packages from Rs. 865 to Rs. 34,999, with genetic testing reaching Rs. 35,000 on the Geniee Platinum tier; a Rs. 999 monthly Doctor's Care Card subscription adds a recurring layer. Reported scale is 30+ million tests processed annually with public discounting of 29%–74% off listed menu prices.

The revenue base is projected by management at Rs. 16 billion for FY2026E and Rs. 20 billion for FY2027, with the company valued at approximately $547 million as of December 2025 following pre-IPO investments of Rs. 1,300 crore from Quadria Capital (2023) and Rs. 940 crore from Kotak Strategic Situations India Fund II (January 2025). A public listing is targeted for 2026 at a raise size of approximately $350 million, with proceeds and existing capital directed toward expansion, M&A, and personalized-medicine capability buildout.

Neuberg Diagnostics firmographics

Firmographics
Name
Neuberg Diagnostics
Legal name
Neuberg Diagnostics Private Limited
Website
https://neubergdiagnostics.com
Company type
Private
Founded year
1938
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Neuberg Diagnostics is an Indian clinical laboratory chain offering 6,000+ pathology and genomic tests through 250+ lab networks and 10,000+ touchpoints. Founded in 2015 by Dr. G.S.K. Velu, it processes 30+ million tests annually across consumers, corporates, and hospitals.
Ownership category
akta.pro rank

Neuberg Diagnostics industry classification

Industry
Product category
Diagnostic Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Diagnostic services
  • Clinical laboratory
  • Pathology testing
  • Genomic testing
  • Corporate wellness

Where Neuberg Diagnostics is headquartered

Location

Headquarters

HQ city
Chennai
HQ country
India
HQ region
Asia

Offices6 records

Markets served

Neuberg Diagnostics business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Clinical Laboratory Testing Services: Core revenue from pathology and radiology diagnostic testing services. Individual tests range from Rs. 85 to Rs. 1,690, with health packages from Rs. 865 to Rs. 34,999. Revenue also generated from specialized tests including genetics and genomics.
  2. Corporate Wellness Programs: B2B services offering comprehensive health packages for corporate employees including pre-employment checks, annual health checks, executive health checks, and on-site health camps across industries.
  3. Hospital Lab Management: Managed services for hospital laboratories including infrastructure upgrade, IT integration, quality accreditation (NABL/ISO/CAP), and process optimization.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual Lab Tests
Unit PricingPay-as-you-goHealth Packages
Unit PricingPay-as-you-goGenetic Testing (GENIEE)
SubscriptionMonthlyDoctor Care Card

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Neuberg Diagnostics product offering

Product offering

Core offering

Neuberg Diagnostics operates clinical laboratory and diagnostic testing services across India, UAE, South Africa, and the USA, offering over 6,000 varieties of pathological investigations including routine pathology, biochemistry, microbiology, hematology, histopathology, molecular biology, oncopathology, and personalized genomics. The company provides direct-to-consumer testing through 250+ lab networks, home sample collection, and digital report delivery, alongside B2B hospital lab management and corporate wellness programs.

Product overview

Neuberg Diagnostics is a multi-channel diagnostic services platform operating as a unified brand across pathology, radiology, and genomics. The core platform offers 6,000+ pathology tests and radiology imaging (X-ray, MRI, ultrasound, CT scan) through 250+ lab networks in India, UAE, South Africa, and the USA, accessible via web portal, mobile app, and home sample collection. The GENIEE sub-brand provides three tiers of personalized genomics products (Platinum, Wellness, Drug Response) which integrate genetic screening with the core diagnostic testing menu. Doctor First is a public health initiative built into the platform to drive appropriate clinical engagement. Corporate Wellness and Hospital Lab Management are B2B add-on modules that extend the core platform to enterprise clients and healthcare institutions.

Differentiator

Problem solved

Functional benefit

Brands

  • Geniee: Personalized genomics platform offering wellness genomics, pharmacogenomics, and genetic health screening. Covers 59 genetic traits for nutrition, fitness, and disease susceptibility; personalized medication response for 170 drugs; and comprehensive risk assessment for 2,300+ genetic conditions.

Products and services

  • Clinical Laboratory Testing Core clinical laboratory testing services including routine pathology, biochemistry, microbiology, hematology, and specialized tests. Tests range from Rs. 85 (Glucose-Fasting) to Rs. 1,690 (25 OH Cholecalciferol). Over 6,000 varieties of pathological investigations are offered across 250+ lab networks in India, with home sample collection and online report delivery. Targets individual patients seeking diagnostic tests.
  • Health Check-up Packages Pre-bundled health check-up packages combining multiple tests at discounted prices, ranging from Rs. 865 (Diabetes Care Basic, 7 tests) to Rs. 34,999 (Geniee Wellness Super Premium). Includes packages like Her Essential Basic (79 tests at Rs. 2,199), Master Health Checkup (105 tests at Rs. 6,480), and Annual Health Checkup variants. Targets individual consumers seeking preventive health screenings.
  • GENIEE Personalized Genomics Platform Personalized genomics sub-brand offering genetic screening across three tiers: GENIEE Platinum (Rs. 35,000, covering wellness genomics, pharmacogenomics for 170+ drugs, and health screening for 2,300+ conditions), GENIEE Wellness (Rs. 22,000, covering 59 wellness traits and pharmacogenomics), and Drug Response tiers. Provides insights on nutrition, fitness, medication response, and hereditary disease risks. Targets health-conscious individual consumers and patients.
  • Corporate Wellness Program B2B corporate wellness services offering comprehensive health packages for corporate employees including pre-employment checks, annual health checks, executive health checks, on-site health camps, and insurance medical checks across banking, IT/ITES, manufacturing, FMCG, PSU, automotive, education, and travel sectors. Targets HR heads and corporate wellness managers.
  • Hospital Lab Management Services Managed services for hospital laboratories including infrastructure upgrade, IT integration with hospital LIS systems, staff training, quality and accreditation support (NABL/ISO/CAP), process optimization, and business development. Targets hospital administrators and healthcare facility operators.
  • Home Sample Collection Home visit sample collection service allowing patients to book sample collection from their homes. Available across service areas with dedicated phone lines (89390 66655) and online booking through website and app. Targets individual consumers preferring at-home convenience.
  • Doctor Care Card Subscription-based membership card for doctors and their families offering 30% off on routine blood tests, free home sample collection, and access to Dr Care Package at Rs. 999 covering Liver Function Test, Kidney function test, CBC, HbA1c, and Vitamin D. Targets medical professionals and their families.

Quantifiable outcome

  • Reduced Sigma metrics computation from 15 days to under 60 minutes for 130 assays through agentic AI implementation
  • +2 more outcomes

Companies that use Neuberg Diagnostics

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Neuberg Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature3 records

Neuberg Diagnostics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • bioMerieuxcoreStrategic or Co-development Partner · 18 July 2024bioMerieux collaborated on Pre-Conference Workshop on Sepsis Solutions at PathFinders 2024. Dr. Debkishore Gupta (Director and Head, Medical Affairs, bioMerieux South Asia) and Dr. Devjani De (Lead, Medical Affairs, bioMerieux South Asia) served as workshop faculty covering antimicrobial interpretation, sepsis diagnostics, and syndromic approach.
  • IAPM (Indian Association of Pathologists and Microbiologists) - Tamil Nadu ChaptercoreStrategic or Co-development PartnerPathFinders 2024 conference organized under the aegis of TamilNadu and Pondicherry Chapter of IAPM - TNCIAPM, focused on 'Integrated Diagnostics: Trends Defining the Future of Diagnostic Medicine'.
  • ITC Grand Chola ChennaiminorOthersConference venue partner for PathFinders 2024 conference held on July 20-21, 2024.
  • Labsystems Diagnostics Oy (Finland)minorStrategic or Co-development PartnerDr. Kumar Shubham (Associate Vice President, Labsystems Diagnostics Oy, Finland) contributed to Pre-Conference Workshop on Newborn Screening Solutions at PathFinders 2024.
  • Trivitron HealthcarecoreStrategic or Co-development PartnerDr. Santosh Devraj Pradhan (Assistant Product Manager, Trivitron Healthcare, India) contributed to Newborn Screening Workshop. GSK Velu is also preparing Trivitron Healthcare for public listing.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Neuberg Diagnostics competitors and assessment

Company assessment

Direct peers

  • Dr. Lal PathLabs: India's largest diagnostic chain by revenue and network. Directly comparable in clinical lab services, B2B hospital partnerships, and home sample collection; Neuberg is positioned as the #4 challenger to Dr. Lal's #1 incumbency.
  • Metropolis Healthcare: Listed Indian diagnostic chain with comparable B2B hospital lab management, corporate wellness, and specialty testing offerings. Competes head-to-head in metros and offers a directly comparable public-market benchmark for Neuberg's pre-IPO valuation.
  • Agilus Diagnostics (formerly SRL Diagnostics): Pan-India diagnostic chain owned by Fortis Healthcare. Overlaps with Neuberg across pathology, reference lab services, hospital partnerships, and corporate wellness — one of the top three players against which Neuberg directly competes.
  • Thyrocare Technologies: Volume-focused diagnostic network acquired by PharmEasy. Directly comparable in low-cost preventive health packages and pan-India B2B2C distribution; competes with Neuberg on package pricing strategy.
  • Apollo Diagnostics: Diagnostic arm of Apollo Hospitals. Directly comparable in hospital-affiliated lab services, preventive health packages, and home sample collection across India, leveraging Apollo's hospital referral network.

Emerging players

  • Pathkind Labs: India-based diagnostic chain expanding aggressively in North and East India. Comparable in B2B hospital lab management and preventive packages; smaller than Neuberg but pursuing similar pan-India consolidation strategy.
  • Healthians: Digital-first Indian diagnostic platform with strong home-sample-collection flywheel. Competes with Neuberg on tech-led DTC booking and at-home preventive packages but lacks reference-lab depth and B2B hospital presence.
  • Tata 1mg Labs: Digital health platform backed by Tata Group offering diagnostic booking. Partially overlaps with Neuberg's DTC booking and home-collection but operates a marketplace model rather than owned labs at Neuberg's scale.

Regional players

  • Suburban Diagnostics: Strong regional diagnostic chain in Western and Central India. Overlaps with Neuberg on B2C pathology, corporate wellness, and home collection but with limited national or international footprint versus Neuberg's 250+ city network.

Others

  • Trivitron Healthcare: Medical technology and IVD company also founded by GSK Velu and slated for IPO. Not a direct competitor but is a sister company and ecosystem participant — provides IVD equipment and reagents, with overlapping newborn screening collaboration at PathFinders 2024.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Neuberg Diagnostics social profiles

Digital presence

Neuberg Diagnostics compliance and trust

Trust signal

Compliance3 records

Neuberg Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Neuberg Diagnostics leadership team

Management profile

Number of profiles

Profiles5 records

Neuberg Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Neuberg Diagnostics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Neuberg Diagnostics M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuberg Diagnostics

What does Neuberg Diagnostics do?

Neuberg Diagnostics operates clinical laboratory and diagnostic testing services across India, UAE, South Africa, and the USA, offering over 6,000 varieties of pathological investigations including routine pathology, biochemistry, microbiology, hematology, histopathology, molecular biology, oncopathology, and personalized genomics. The company provides direct-to-consumer testing through 250+ lab networks, home sample collection, and digital report delivery, alongside B2B hospital lab management and corporate wellness programs.

Is Neuberg Diagnostics a public or private company?

Neuberg Diagnostics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Neuberg Diagnostics founded?

Neuberg Diagnostics was founded in 1938. It employs 1,001 to 5,000 people.

Where is Neuberg Diagnostics based?

Neuberg Diagnostics is headquartered in Chennai, India, in the Asia region.

How does Neuberg Diagnostics make money?

Three revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are corporate Wellness Programs and hospital Lab Management.

Who are Neuberg Diagnostics's main competitors?

Direct peers on record are Dr. Lal PathLabs, Metropolis Healthcare, Agilus Diagnostics (formerly SRL Diagnostics), Thyrocare Technologies and Apollo Diagnostics. Emerging players are Pathkind Labs, Healthians and Tata 1mg Labs. Suburban Diagnostics is listed as a regional player. Trivitron Healthcare is listed as an others.

Does Neuberg Diagnostics have an API?

No public API is recorded for Neuberg Diagnostics.

What industry is Neuberg Diagnostics in?

Neuberg Diagnostics's product category is Diagnostic Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Fortune IndiaMS Dhoni launches combined Maharashtra diagnostics operations of Neuberg and NM MedicalMS Dhoni unveiled a combined Maharashtra diagnostics platform on October 3, merging Neuberg Diagnostics and NM Medical. The network integrates pathology, radiology, genomics, and preventive wellness, with Dr Nilesh Shah as chairman. Neuberg processes over 30 million tests annually across 250+ laboratories.Digital Health NewsNeuberg Diagnostics, NM Medical Consolidate Maharashtra Operations to Build Integrated Diagnostics NetworkNeuberg Diagnostics and NM Medical consolidated their Maharashtra operations, uniting diagnostic brands under a unified network. The platform combines radiology, pathology, genomics, and preventive wellness, with Dr. Nilesh Shah as chairman. The first Atlas Longevity & Wellness programme launched at NM Medical's Marine Lines centre in Mumbai.BusinessLineNeuberg Diagnostics consolidates Maharashtra operations with NM MedicalNeuberg Diagnostics announced consolidation of its Maharashtra operations with NM Medical, combining NM Medical's radiology, cardiology, and wellness expertise with Neuberg's genomics, metabolomics, and digital pathology capabilities. The partnership aims to provide patients in Mumbai and Maharashtra with convenient access to routine and specialized testing. Additionally, the unification of Neuberg's diagnostic brands with Atlas was unveiled by MS Dhoni on 3 October 2026.Business News TodayNeuberg Diagnostics acquires NM Medical as it gears up for IPO, expands Maharashtra footprint- Moneycontrol.comNeuberg Diagnostics acquired Mumbai-based NM Medical, integrating its radiology and preventive wellness into its Maharashtra operations ahead of a potential IPO. The deal valued NM Medical at Rs 800-850 crore, with revenue of Rs 200 crore. Neuberg expects to file its DRHP in the next few months and complete the IPO next year.The Times of IndiaNeuberg Diagnostics consolidates its Maharashtra operations with NM MedicalNeuberg Diagnostics is consolidating its Maharashtra operations with NM Medical, combining NM Medical's radiology and preventive wellness with Neuberg's genomics and pathology capabilities. The partnership aims to create an integrated diagnostic platform, with Maharashtra expected to become Neuberg's largest state market. Neuberg plans to raise about Rs 3,500-4,000 crore through an IPO in FY28.Medical BuyerNeuberg Diagnostics, NM Medical to set up diagnostics network in MaharashtraNeuberg Diagnostics consolidated its Maharashtra operations with NM Medical, uniting diagnostic brands under one network. The partnership combines NM Medical's radiology and cardiology expertise with Neuberg's genomics and molecular diagnostics. MS Dhoni unveiled the platform on 3 October 2026, with Atlas's first longevity programme launching at NM Medical's Marine Lines centre.Digital Health NewsNeuberg Diagnostics & ProLife Announce Joint Venture to Expand Diagnostic Services Across OdishaNeuberg Diagnostics and ProLife Diagnostics announced a joint venture to expand diagnostic services across Odisha. The venture plans to establish 10 integrated centres and over 100 satellite laboratories in cities like Bhubaneswar and Cuttack. The hub-and-spoke model aims to extend services to Tier-II and Tier-III markets.The HinduMahajan Imaging & Labs has entered a joint venture partnership with Neuberg DiagnosticsMahajan Imaging & Labs and Neuberg Diagnostics entered a joint venture to expand pathology and wellness services across north India. The partnership combines Mahajan's radiology and imaging capabilities with Neuberg's pathology and genomics expertise, aiming to create an integrated diagnostic pathway. The collaboration seeks to make diagnostics more accessible and affordable, with faster reporting and consolidated reports.Indian Economic Observer"AI is integral to diagnosis": Neuberg Diagnostics' MD GSK Velu on future of healthcareGSK Velu, MD of Neuberg Diagnostics, said AI is integral to diagnosis in pathology and radiology, enabling faster processing of scans. He noted the company operates genomics centers in Ahmedabad, Chennai, and a new Delhi center, plus metabolomics and renal pathology facilities. He also highlighted a joint venture with Mahajan Imaging & Labs.Ani News"AI is integral to diagnosis": Neuberg Diagnostics' MD GSK Velu on future of healthcareGSK Velu, MD of Neuberg Diagnostics, said AI is integral to diagnosis in pathology and radiology, enabling faster processing of scans. He noted the company operates genomics and metabolomics centers, with a new Delhi center launching, and highlighted a joint venture with Mahajan Imaging & Labs combining pathology and imaging strengths.